arrow
M

Mona Amini-Adlé

centre leon berard
H指数:14
被引数:600

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohort

NF1相关性和散发性恶性周围神经鞘瘤的临床决定因素、诊断复杂性和分子异质性:一项25年转诊中心队列研究

2026-07-080
PRE
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)

III期黑色素瘤切除术后辅助治疗的生存结局:真实世界队列研究(TAMARIS)的结果

2026-06-250
PRE
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1

肿瘤内抗CTLA4联合静脉注射抗PD1的安全性和有效性

Nature
IF48.5
2026-04-290
OAAI
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)

COVID-19疫情对黑色素瘤的影响:一项来自法国黑色素瘤患者临床数据库(RIC-Mel)的回顾性研究

2025-09-040
PRE
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL)

Nardin C,Cavalieri C,Lebbé C,Gérard E,Puyraveau M,Vergara R,等人. 可切除III/IV期黑色素瘤患者的新辅助免疫检查点抑制剂治疗:一项法国全国性真实世界研究(NEOMEL). 英国皮肤病学杂志. (2025) 7:ljaf268. doi: 10.1093/bjd/ljaf268.

2025-07-140
PRE
Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin

接受恩沃利单抗 vedotin 治疗的患者中,药物相关皮肤不良事件与生存结局的关联。

2025-06-010
OAAI
Effectiveness, safety and reasons for discontinuation of sonidegib for patients with locally advanced basal cell carcinoma: A real-word evidence analysis from the French national registry CARADERM
2024-12-160
PRE
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients
2024-06-260
OA
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network
2024-06-120
OAAI